Drugs / Florence
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02873468 | Apr 2021 → Jul 2025 | eosinophilic esophagitis | EMS | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Florence | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02873468 ↗ |
| Route | Oral | “10 mL, oral, twice a day.” NCT02873468 ↗ |